We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

US intelligence services advised the authors of the BIOSECURE Act that that WuXi AppTec shared confidential data on US customers with the Chinese government, according to a Reuters report.

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative ...

Engineered Exosomes Drug Landscape Report 2025: Market is Dominated by Biologics, with a Focus on Intravenous Administration and Oncology Therapies Research and Markets Fri, Mar 14, 2025, 8:25 AM ...

In the latest draft report, WuXi Biologics was also added to the list of named companies that are considered of concern. In the last six months, WuXi Biologics’ share price has fallen by over 70 ...

1 Day WXXWY 0.91% DJIA 1.14% S&P 500 1.39% Health Care/Life Sciences 0.19% ...

9995.HK RemeGen Co., Ltd.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...